NCT06315075

Brief Summary

The goal of this pre-post-follow-up study is to examine how well the treatment Dialectical behavior therapy for adolescents (DBT-A) with a duration of 20 weeks for adolescents with self-harm and suicidal behavior works in routine clinical practice. The main questions it aims to answer are:

  • to investigate how well DBT-A works after treatment and at 3-month follow-up, measured by episodes of self-harm, suicide attempts, depressive symptoms and quality of life, drop-out from treatment and number of possible participants who decline DBT-A.
  • to investigate how well DBT-A works at 12 months follow-up
  • to investigate whether pre-treatment factors can predict who will benefit from treatment

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
45mo left

Started Jan 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
Jan 2024Dec 2029

Study Start

First participant enrolled

January 15, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 27, 2024

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 18, 2024

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2029

Last Updated

January 22, 2026

Status Verified

January 1, 2026

Enrollment Period

4 years

First QC Date

February 27, 2024

Last Update Submit

January 20, 2026

Conditions

Keywords

Suicide and Self-harmAdolescentsDialectical behavior therapy for adolescentsRoutine clinical practiceEffectiveness study

Outcome Measures

Primary Outcomes (2)

  • Lifetime Parasuicide Count Interview

    Number of self-harm episodes in the last four weeks categorized by intention and self-harm method, number of suicide attempts, and number of emergency department visits caused by suicidal behavior.

    pre, after 20 weeks DBT-A ("post"), at 3 and 12 months follow-up

  • Number of participants in need of emergency department visits caused by suicidal behavior

    Medical record data extraction

    pre, after 20 weeks DBT-A ("post"), at 3 and 12 months follow-up

Secondary Outcomes (4)

  • Depressive symptom score measured by Short Mood and Feelings questionnaire (SMFQ)

    pre, after 20 weeks DBT-A ("post"), 3 and 12 months follow-up

  • Health related quality of life measured by SCREENing for and Promotion of Health Related Quality of Life in Children an Adolescents (Kidscreen 10)

    pre, after 20 weeks DBT-A ("post"), 3 and 12 months follow-up

  • Barriers to Treatment Participation Scale (BTPS) score

    pre, at dropout at any time between session 1 and end of treatment at session 20.

  • Perceived benefit of skills training in DBT-A measured by a study specific questionnaire.

    At dropout at any time between session 1 and end of treatment at session 20, or for completers after 20 weeks DBT-A ("post"),

Study Arms (1)

DBT-A

EXPERIMENTAL

Single group uncontrolled study. All participants will receive DBT-A

Behavioral: Dialectical behavior therapy for adolescents (DBT-A)

Interventions

A 20-week DBT-A with a weekly individual session (45 minutes), a weekly session of multifamily skills training groups with a caregiver (120 minutes), and telephone consultation with individual therapists outside therapy sessions as needed. The treatment consists of four components and is delivered according to the manual except for the phone coaching that PBU offers workdays until 8 pm.

Also known as: DBT-A
DBT-A

Eligibility Criteria

Age13 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age 13-18 years
  • Ongoing or a history of self-harm the last six months; current suicidal behavior (suicidal thoughts or at least one suicide attempt within the previous six months); at least three criteria of Diagnostic and Statistical Manual -5 (DSM-5) Borderline personality disorder (BPD), or the self-destruction criterion of DSM-5 BPD in addition to minimum two subthreshold criteria as assessed by the Structured Clinical Interview for DSM-5 Personality Disorders (SCID-5-PD) (First et al., 2016)
  • Fluency in Norwegian
  • One parent/trusted adult that can participate together with the adolescent.

You may not qualify if:

  • Intellectual disability
  • Significant learning or language impairments
  • Autism spectrum disorder
  • Anorexia Nervosa
  • Any psychotic disorder
  • Substance abuse disorder. These patients will be offered treatment as usual at their local outpatient clinic.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dept. of child and adolescent psychiatry, Haukeland University Hospital

Bergen, Bergen, 5021, Norway

RECRUITING

MeSH Terms

Conditions

Self-Injurious BehaviorSuicidal IdeationSuicide

Interventions

Dialectical Behavior Therapy

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Gro Janne H. Wergeland, MD, PhD

    Haukeland University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gro Janne H. Wergeland, MD, PhD

CONTACT

Anne Mari Syversen, Psychol

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
An independent evaluator will assess participants at post treatment and one year follow-up. Due to the single group design, the assessor will be aware that participants have received the intervention, but will not be involved in recruitment and treatment.
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Single group, uncontrolled, pre-post-one year follow-up study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2024

First Posted

March 18, 2024

Study Start

January 15, 2024

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2029

Last Updated

January 22, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations